Deutsche Bank
FMTX

Deutsche Bank’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Deutsche Bank’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,151
Closed -$302K – 4150
2022
Q3 		$302K Sell
15,151
-942
-6% -$12.4K ﹤0.01% 2688
2022
Q2 		$111K Sell
16,093
-2,332
-13% -$16.4K ﹤0.01% 3481
2022
Q1 		$171K Sell
18,425
-481,198
-96% -$5.12M ﹤0.01% 3351
2021
Q4 		$7.1M Sell
499,623
-3,618
-0.7% -$62.6K ﹤0.01% 1265
2021
Q3 		$11.7M Buy
503,241
+3,150
+0.6% +$74.5K 0.01% 1087
2021
Q2 		$12.4M Buy
500,091
+996
+0.2% +$26.8K 0.01% 1084
2021
Q1 		$14M Buy
499,095
+478,200
+2,289% +$17.3M 0.01% 1038
2020
Q4 		$729K Buy
20,895
+12,280
+143% +$535K ﹤0.01% 2660
2020
Q3 		$430K Buy
+8,615
New +$348K ﹤0.01% 2750

Deutsche Bank's FMTX Position: Q4 2022 in Review

Deutsche Bank sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 15,151 shares — an estimated $302K sold.

Deutsche Bank first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $14M in Q1 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Deutsche Bank reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Deutsche Bank sold 15,151 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $302K.
  • Deutsche Bank first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Deutsche Bank's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $14M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Deutsche Bank's 13F filing for Q4 2022, filed 13 Feb 2023.